基本信息

　　姓名：趙永達(dá)         性別：男

　　政治面貌：中共黨員

　　學(xué)位：博士         職稱(chēng)：教授

　　聯(lián)系方式：Tel: 18266427955    E-mail: ydzhao_house@126.com

　　現(xiàn)任職務(wù)及社會(huì)兼職情況：現(xiàn)任青島農(nóng)業(yè)大學(xué)動(dòng)物醫(yī)學(xué)院基礎(chǔ)獸醫(yī)學(xué)專(zhuān)業(yè)教授

　　教育背景

　　1. 2011年6月-2015年6月，國(guó)家動(dòng)物用保健品工程技術(shù)研究中心，新獸藥注冊(cè)部經(jīng)理

　　2. 2018年6月-至今，青島農(nóng)業(yè)大學(xué)  動(dòng)物醫(yī)學(xué)院，獸醫(yī)藥理教研室

　　3. 2018年畢業(yè)于華南農(nóng)業(yè)大學(xué)獸醫(yī)藥理與毒理學(xué)方向，獲得農(nóng)學(xué)博士學(xué)位。

　　研究方向

　　主要研究方向?yàn)樗幬锎x動(dòng)力學(xué)、藥效學(xué)、藥動(dòng)-藥效學(xué)同步模型、殘留檢測(cè)、新獸藥開(kāi)發(fā)與評(píng)價(jià)、國(guó)家新獸藥創(chuàng)制及安全評(píng)價(jià)研究等。

　　主持或參與課題、項(xiàng)目情況

　　1.主持山東省新舊動(dòng)能轉(zhuǎn)換重大課題重大攻關(guān)項(xiàng)目課題“畜禽呼吸道疾病防治新型獸用原料及其制劑的開(kāi)發(fā)”

　　2.主持橫向課題“吡蟲(chóng)啉、布他磷系列新獸藥的制備及藥學(xué)評(píng)價(jià)”

　　3.主持橫向課題“國(guó)家二類(lèi)新獸藥吡蟲(chóng)啉的研制”

　　4.主持橫向課題“國(guó)家新獸藥復(fù)方咪康唑香波的研制”

　　發(fā)表論文、編著、榮譽(yù)獎(jiǎng)項(xiàng)、專(zhuān)利軟著等情況

　　發(fā)表論文：

　　1. Yongda Zhao; Bao-tao Liu; Li-li Guo; Hu Shan*; Binghu Fang*. A novel experimental intraperitoneal infection model for Haemophilus parasuis in neutropenic guinea pigs. Journal of Pharmacological and Toxicological Methods, 2018.11.23, 95: 27~35

　　2.  Yongda Zhao; Lili Guo; Jie Li; Xianhui Huang; Binghu Fang*. Characterization of antimicrobial resistance genes in Haemophilus parasuis isolated from pigs in China. PeerJ, 2018.4.9, 6: 0~e4613

　　3. Yongda Zhao; Qin Wang; Jie Li; Xiaohuan Lin; Xianhui Huang; Binghu Fang*. Epidemiology of Haemophilus parasuis isolates from pigs in China using serotyping, antimicrobial susceptibility, biofilm formation and ERIC-PCR genotyping. PeerJ, 2018.6.13, 6: 0~e5040

　　4. Yongda Zhao; Lili Guo; Jie Li; Binghu Fang (*); Xianhui Huang *. Molecular epidemiology, antimicrobial susceptibility, and pulsed-field gel electrophoresis genotyping of Pseudomonas aeruginosa isolates from mink. Canadian Journal of Veterinary Research, 2018.10, 82(4): 256~263

　　5. Yongda ZHao; Lili Guo; Binghu Fang*; Baotao Liu*. Pharmacokinetic/ pharmacodynamic (PK/PD) evaluation of tulathromycin against Haemophilus parasuis in an experimental neutropenic guinea pig model. PLOS ONE, 2018.12.31, 131(12)

　　6. Ming Zou, Guifang Guo, Yongda Zhao, Qidi Zhang. Detection, quantifications, and pharmacokinetics of ponazuril in healthy swine. Journal of Veterinary Pharmacology and Therapeutics.2014.37: 598-602.

　　7. Xianhui Huang, Yongda Zhao, Limin He, Zisen Liang, Lili Guo, Zhengling Zeng, et al. Development of High-Performance Liquid Chromatography-Tandem Mass Spectrometry Method for the Detection of Tulathromycin in Swine Plasma. Journal of Integrative Agriculture 2012, 11(3), 465-473.

　　8. Hao, Z.H., Zhao, Y.D., Wu, H.T., Hao, L.H., Ding, Z.P., Yang, F.F., Qu, B.H. The Physiological and Biochemical Evaluation of Tulathromycin Premix in Pigs. J Anim Vet Adv 2012, 11:4161-4166.

　　9. Hao, Z.H., Zhao, Y.D., Qu, B.H., Wu, H.T., Hao, L.H., Ding, Z.P., Yang, F.F., Li, Y., 2012. Comparative Pharmacokinetics of Two Injection Formulations of Tulathromycin after a Single Intramuscular Administration in Healthy Swine. J Anim Vet Adv. 2012,11: 4201-4204.

　　10. Hao, Zhihui; Wang, Leilei; Xiao, Xiao, Kefeng; Zhao, Yongda; Zou, Ming; Zhang, Qidi; Ding, Zhaopeng; Yang, Fenfang; Qu, Baohan*. In vivo investigation of ceftiofur-loaded gelatin and PLGA microspheres in beagle dogs. Journal of Materials Science. 2013

　　11. Guo Lili; Zhang Jianmin; Xu Chenggang; Zhao Yongda; Ren Tao; Zhang Bin; Fan Huiying; Liao Ming*. Molecular characterization of fluoroquinolone resistance in Haemophilus parasuis isolated from pigs in South China. Journal of Antimicrobial Chemotherapy, 2011, 66(3): 539~542